Article Versions Notes

Tsakiridou G, Angelerou M-F-G, Efentakis P, Margaritis A, Papanastasiou A-M, Kalantzi L. Partial AUCs in Long-Acting Injectables: Rationale, Challenges, Variability, Usefulness, and Clinical Relevance. Pharmaceutics. 2025; 17(1):21. https://doi.org/10.3390/pharmaceutics17010021

Tsakiridou, Georgia, Maria-Faidra-Galini Angelerou, Panagiotis Efentakis, Antonios Margaritis, Antigoni-Maria Papanastasiou, and Lida Kalantzi. 2025. "Partial AUCs in Long-Acting Injectables: Rationale, Challenges, Variability, Usefulness, and Clinical Relevance" Pharmaceutics 17, no. 1: 21. https://doi.org/10.3390/pharmaceutics17010021

Tsakiridou, G., Angelerou, M.-F.-G., Efentakis, P., Margaritis, A., Papanastasiou, A.-M., & Kalantzi, L. (2025). Partial AUCs in Long-Acting Injectables: Rationale, Challenges, Variability, Usefulness, and Clinical Relevance. Pharmaceutics, 17(1), 21. https://doi.org/10.3390/pharmaceutics17010021